16.24 USD
↗ 0.06 (0.37%)AT CLOSE (03:59 PM EST)
PERRIGO COMPANY PLC
PRGONYSE • USD
16.26
↗ 0.02 (0.09%)
POST MARKET (AS OF 07:51 PM EST)
Post Market
AS OF 07:51 PM EST
16.26
↗ 0.02 (0.09%)
Market: CLOSED
PERRIGO COMPANY PLC (PRGO) trades at $16.28 per share. PRGO shows a split signal: technical indicators suggest "Buy" while underlying fundamentals indicate "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation side, PRGO appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Nov 13, 2026.
Open?$16.29
High?$16.45
Low?$16.14
Prev. Close?$16.18
Volume?1.0M
Avg. Volume?2.4M
VWAP?$16.29
Rel. Volume?0.42x
Bid / Ask
Bid?$16.25 × 500
Ask?$16.50 × 100
Spread?$0.25
Midpoint?$16.38
Valuation & Ratios
Market Cap?2.2B
Shares Out?138.8M
Float?138.2M
Float %?99.6%
P/E Ratio?N/A
P/B Ratio?0.92
EPS?-$12.75
Dividend?7.13%
Ex-Dividend?2026-11-27
News
Profile
Perrigo is a pure-play consumer healthcare product manufacturer and distributor. In North America (two-thirds of total sales), the firm's product mix centers on private-label consumer health goods sold to major retailers such as Walmart, Amazon.com, Costco, and CVS. It plays in a number of over-the-counter categories including pain, skincare, women's health, and nutrition. Perrigo also competes in Europe, Australia, and parts of Asia, where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Employees
8.1K
Market Cap
2.2B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1991-12-16
Address
THE SHARP BUILDING
DUBLIN 2, L2 D02 TY74
Phone: 269-673-8451
DUBLIN 2, L2 D02 TY74
Phone: 269-673-8451
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?1
Momentum?65
Short Sent.?19
Piotroski F-Score?1/9Weak
Altman Z-Score?-0.43Distress
Confidence?62%Moderate
Short InterestVery High
Short % of Float?17.80%High
Short Interest?24.6M
Days to Cover?11.3
Free Float138.2M
Avg Daily Volume2.2M
Settlement Date2026-10-30
Financial Health
Current Ratio?2.35Strong
Quick Ratio?1.36Adequate
Cash Ratio?0.43Low
Debt/Equity?1.35Moderate
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.92CHEAP▾
Peers100
S&P97
P/S?0.55CHEAP▾
Peers100
S&P95
P/FCF?13.4CHEAP▾
Peers100
S&P79
EV/EBITDA?9.6CHEAP▾
Peers100
S&P83
EV/Sales?1.25CHEAP▾
Peers100
S&P88
Returns & Efficiency
ROE?-72.5%WEAK▾
S&P3
ROA?-23.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$168.2M
Enterprise Value?$5.1B
Fundamentals ratios updated end of day